PTC Therapeutics, Inc.
NASDAQ: PTCT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Matthew Klein
- Employees
- 939
- Headquarters
- Warren, United States
- IPO year
- 2013
- Market cap
- $6.6B
- Website
- https://www.ptcbio.com
Loading PTCT…
Loading profile data…Frequently asked questions about PTCT
What does PTC Therapeutics, Inc. (PTCT) do?
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from...
Where does PTCT trade?
PTC Therapeutics, Inc. (PTCT) trades on the NASDAQ Global Select.
What sector is PTCT in?
PTC Therapeutics, Inc. (PTCT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PTC Therapeutics, Inc.?
Matthew Klein is the chief executive officer of PTC Therapeutics, Inc. (PTCT).
Where is PTC Therapeutics, Inc. headquartered?
PTC Therapeutics, Inc. is headquartered in United States.
Does PTCT pay a dividend?
PTC Therapeutics, Inc. (PTCT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PTCT go public?
PTC Therapeutics, Inc. (PTCT) completed its initial public offering in 2013.